logo.jpg
ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases
December 04, 2019 00:45 ET | ImCheck Therapeutics SAS
-- Bpifrance and Pfizer Ventures co-led international investor syndicate -- Marseille, France, December 04, 2019, 6:45 AM CET – ImCheck Therapeutics, a biotech company developing a first-in-class...
Paul_Frohna_CMO
ImCheck Therapeutics appoints Paul Frohna MD, PhD, PharmD,as Chief Medical Officer
July 20, 2019 11:00 ET | ImCheck Therapeutics SAS
Paul Frohna brings over 15 years of experience in translational medicine and clinical and regulatory strategy Marseille, France, 18 July 2019 – ImCheck Therapeutics, a biotech company on the cutting...
ImCheck Therapeutics lève 20 M€ et recrute son Président
May 02, 2017 11:59 ET | ImCheck Therapeutics SAS
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ImCheck Therapeutics lève 20 M€ et...
ImCheck Therapeutics raises €20 Million and appoints its CEO
May 02, 2017 11:59 ET | ImCheck Therapeutics SAS
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ImCheck Therapeutics raises €20...